세계의 랩온스킨 마이크로플루이딕 패치 시장 보고서(2025년)
Lab-On-Skin Microfluidic Patch Global Market Report 2025
상품코드 : 1877805
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

랩온스킨 마이크로플루이딕 패치 시장 규모는 최근, 비약적으로 확대하고 있습니다. 2024년 12억 달러로 평가되었고, 2025년에는 14억 4,000만 달러에 달하고, CAGR 20.3%로 성장할 것으로 예상되고 있습니다. 지난 몇 년간의 성장은 만성 질환과 생활 습관병 증가, 비침습적 진단 솔루션에 대한 수요 증가, 지속적인 건강 모니터링에 대한 의식 향상, 맞춤형 의료 접근의 급증, 재택치료 서비스의 확대, 예방적 건강 관리에 중시 증가 등이 요인으로 생각됩니다.

랩온스킨 마이크로플루이딕 패치 시장 규모는 앞으로 수년간 급속한 성장이 예상됩니다. 2029년에는 29억 8,000만 달러에 달하고, CAGR은 20.0%를 나타낼 전망입니다. 예측 기간 중 성장 요인으로는 웨어러블 건강 모니터링 장치의 보급 확대, 개발 도상지역의 의료비 지출 증가, 원격 환자 모니터링에 대한 주목 증가, 디지털 건강 추진을 위한 정부의 대처 강화, 신흥 경제국의 의료 인프라 확충, 실시간 건강 정보 소비자 수요 증가 등이 있습니다. 이 기간에 예상되는 주요 동향으로는 바이오센싱 재료 및 마이크로플루이딕스 통합 기술의 진보, 유연성 및 생체적합성 기판의 개선, 무선 데이터 전송 및 연결성의 혁신, 땀 및 조직간액 분석 방법의 진보, 다성분 검출 플랫폼에서의 지속적인 연구 개발, 에너지 절약형 및 자기발전형 패치 시스템의 출현 등이 있습니다.

개인화된 의료에 대한 관심 증가는 앞으로 수년간 랩온스킨 마이크로플루이딕 패치 시장의 확대를 이끌 것으로 예측됩니다. 맞춤형 의료는 치료 효과를 향상시키기 위해 개인의 유전자 정보, 바이오마커, 임상 프로파일을 기반으로 의료 치료 및 예방 전략을 맞춤화하는 의료 접근법입니다. 유전체학와 생명공학의 진보로 치료효과를 높이고 불필요한 개입을 줄이는 정확한 진단과 표적요법이 가능해져 개별화의 도입이 확대되고 있습니다. 랩온스킨 마이크로플루이딕 패치는 독특한 바이오마커를 지속적으로 모니터링하여 실시간으로 맞춤 치료 결정을 가능하게 하고 이 접근법에 기여합니다. 예를 들어 2024년 2월 미국 비영리 단체 '맞춤형 의료연합(PMC)'이 발표한 바에 따르면 미국 식품의약국(FDA)은 2023년 희소질환 환자를 위한 신규맞춤형 치료를 16건 승인했습니다. 이것은 2022년 6건에서 크게 증가한 수치입니다. 따라서 맞춤형 의료에 대한 관심 증가는 랩온스킨 마이크로플루이딕 패치 시장의 성장을 가속하고 있습니다.

랩온스킨 마이크로플루이딕 패치 시장에서 사업을 전개하는 기업은 실시간 건강 모니터링 및 개인화 진단을 지원하기 위해 땀 감지 패치와 같은 고급 마이크로플루이딕스 기술을 개발하고 있습니다. 땀 감지 패치는 땀을 수집하고 분석하여 바이오 마커, 전해질 및 기타 생리적 지표를 지속적으로 추적하는 웨어러블 장치입니다. 예를 들어, 2024년 4월에는 미국에 본사를 둔 디지털 건강 기업인 Epicore Biosystems Inc.가 모바일 애플리케이션과 연동하는 웨어러블 마이크로플루이딕스 패치인 Connected Hydration을 발표했습니다. 이것은 산업 노동자가 지속적인 땀과 전해질 모니터링을 통해 탈수 증상과 열 스트레스를 예방하는 데 도움이 됩니다. 피로와 부상이 발생하기 전에 수분 섭취를 최적화하기 위해 실시간 개별화된 수분 공급에 대한 통찰력, 진동 경보 및 AI 기반 권장 사항을 제공합니다. 피부 랩 센싱 기술, 클라우드 기반 분석, 긴 수명 배터리 시스템을 통합한 'Connected Hydration'은 세계 산업 분야에서 가혹한 고온 환경에서 근로자의 안전, 생산성 및 지구력 향상에 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A lab-on-skin microfluidic patch is a wearable device that combines microfluidic technology with a flexible, skin-adhering surface to continuously collect and analyze biofluids such as sweat, interstitial fluid, or tears. It operates as a compact laboratory on the skin, allowing real-time monitoring of physiological indicators such as electrolytes, glucose, lactate, and hydration levels for applications in health diagnostics, athletic performance, and personalized medicine.

The primary product types of lab-on-skin microfluidic patches include diagnostic patches, therapeutic patches, monitoring patches, and others. Diagnostic patches are skin-worn devices designed to detect and identify biomarkers such as ions, metabolites, or proteins that reflect disease states or physiological conditions. These patches are composed of materials such as polymer-based, paper-based, hybrid, and others. They are used in healthcare monitoring, disease diagnosis, drug delivery, sports and fitness, and other applications, serving end-users such as hospitals and clinics, homecare, research institutes, sports and fitness centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The lab-on-skin microfluidic patch market research report is one of a series of new reports from The Business Research Company that provides lab-on-skin microfluidic patch market statistics, including lab-on-skin microfluidic patch industry global market size, regional shares, competitors with a lab-on-skin microfluidic patch market share, detailed lab-on-skin microfluidic patch market segments, market trends and opportunities, and any further data you may need to thrive in the lab-on-skin microfluidic patch industry. This lab-on-skin microfluidic patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lab-on-skin microfluidic patch market size has grown exponentially in recent years. It will grow from $1.20 billion in 2024 to $1.44 billion in 2025 at a compound annual growth rate (CAGR) of 20.3%. Growth during the historic period can be attributed to the rising prevalence of chronic and lifestyle-related diseases, increasing demand for non-invasive diagnostic solutions, growing awareness of continuous health monitoring, the surge in personalized healthcare approaches, expansion of home-based healthcare services, and the increasing emphasis on preventive health management.

The lab-on-skin microfluidic patch market size is expected to see rapid growth in the next few years. It will grow to $2.98 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. Growth during the forecast period can be attributed to the rising adoption of wearable health monitoring devices, increasing healthcare spending in developing regions, growing emphasis on remote patient monitoring, surge in government efforts to promote digital health, expansion of healthcare infrastructure in emerging economies, and growing consumer demand for real-time health insights. Key trends expected in this period include technological progress in biosensing materials and microfluidic integration, improvements in flexible and biocompatible substrates, innovations in wireless data transmission and connectivity, advancements in sweat and interstitial fluid analysis methods, ongoing research and development in multi-analyte detection platforms, and the emergence of energy-efficient and self-powered patch systems.

The growing focus on personalized medicine is anticipated to drive the expansion of the lab-on-skin microfluidic patch market in the coming years. Personalized medicine is a healthcare approach that tailors medical treatment and preventive strategies to an individual's genetic, biomarker, and clinical profile to achieve better therapeutic outcomes. The increasing adoption of personalized medicine is supported by advances in genomics and biotechnology, which enable accurate diagnoses and targeted therapies that enhance treatment effectiveness and reduce unnecessary interventions. Lab-on-skin microfluidic patches contribute to this approach by continuously monitoring unique biomarkers, allowing real-time, individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization promoting personalized medicine, the US Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Therefore, the rising emphasis on personalized medicine is propelling the growth of the lab-on-skin microfluidic patch market.

Companies operating in the lab-on-skin microfluidic patch market are increasingly developing advanced microfluidic technologies, such as sweat-sensing patches, to support real-time health monitoring and personalized diagnostics. A sweat-sensing patch is a wearable device that collects and analyzes sweat to track biomarkers, electrolytes, and other physiological indicators continuously. For example, in April 2024, Epicore Biosystems Inc., a US-based digital health company, launched Connected Hydration, a wearable microfluidic patch paired with a mobile application that helps industrial workers prevent dehydration and heat stress through continuous sweat and electrolyte monitoring. It offers real-time personalized hydration insights, vibration alerts, and AI-based recommendations to optimize fluid intake before fatigue or injury occurs. By integrating lab-on-skin sensing, cloud-based analytics, and a long-lasting battery system, Connected Hydration improves worker safety, productivity, and endurance in extreme heat environments across global industrial sectors.

In February 2024, Epicore Biosystems Inc. entered into a partnership with the US Anti-Doping Agency (USADA) to advance its microfluidic sweat patch technology for doping detection. This collaboration aims to enable non-invasive sweat biomarker collection for drug testing, improving the efficiency and convenience of anti-doping procedures while providing athletes with real-time health insights. The US Anti-Doping Agency is a US-based nonprofit and non-governmental organization responsible for implementing a comprehensive anti-doping program for ParaPan American sports in the United States.

Major players in the lab-on-skin microfluidic patch market are Abbott Laboratories, Medtronic plc, GE HealthCare Technologies Inc., Persperity Health Inc., Biolinq Inc., VivaLNK Inc., Blue Spark Technologies Inc., GraphWear Technologies Inc., Nutromics Pty Ltd., Aline Inc., Caliber Imaging & Diagnostics Inc., Flow Bio Ltd., GENTAG Inc., Nemaura Medical Inc., Zansors LLC, Epicore Biosystems Inc., Kenzen Inc., Xsensio SA, Rhaeos Inc., and PointFit Technology Co. Ltd.

North America was the largest region in the lab-on-skin microfluidic patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lab-on-skin microfluidic patch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lab-on-skin microfluidic patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab-on-skin microfluidic patch market consists of sales of sensors, microfluidic chips, flexible substrates, electrodes, biosensors, hydrogels, and wearable bands. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab-On-Skin Microfluidic Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab-on-skin microfluidic patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lab-on-skin microfluidic patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab-on-skin microfluidic patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Lab-On-Skin Microfluidic Patch Market Characteristics

3. Lab-On-Skin Microfluidic Patch Market Trends And Strategies

4. Lab-On-Skin Microfluidic Patch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lab-On-Skin Microfluidic Patch Growth Analysis And Strategic Analysis Framework

6. Lab-On-Skin Microfluidic Patch Market Segmentation

7. Lab-On-Skin Microfluidic Patch Market Regional And Country Analysis

8. Asia-Pacific Lab-On-Skin Microfluidic Patch Market

9. China Lab-On-Skin Microfluidic Patch Market

10. India Lab-On-Skin Microfluidic Patch Market

11. Japan Lab-On-Skin Microfluidic Patch Market

12. Australia Lab-On-Skin Microfluidic Patch Market

13. Indonesia Lab-On-Skin Microfluidic Patch Market

14. South Korea Lab-On-Skin Microfluidic Patch Market

15. Western Europe Lab-On-Skin Microfluidic Patch Market

16. UK Lab-On-Skin Microfluidic Patch Market

17. Germany Lab-On-Skin Microfluidic Patch Market

18. France Lab-On-Skin Microfluidic Patch Market

19. Italy Lab-On-Skin Microfluidic Patch Market

20. Spain Lab-On-Skin Microfluidic Patch Market

21. Eastern Europe Lab-On-Skin Microfluidic Patch Market

22. Russia Lab-On-Skin Microfluidic Patch Market

23. North America Lab-On-Skin Microfluidic Patch Market

24. USA Lab-On-Skin Microfluidic Patch Market

25. Canada Lab-On-Skin Microfluidic Patch Market

26. South America Lab-On-Skin Microfluidic Patch Market

27. Brazil Lab-On-Skin Microfluidic Patch Market

28. Middle East Lab-On-Skin Microfluidic Patch Market

29. Africa Lab-On-Skin Microfluidic Patch Market

30. Lab-On-Skin Microfluidic Patch Market Competitive Landscape And Company Profiles

31. Lab-On-Skin Microfluidic Patch Market Other Major And Innovative Companies

32. Global Lab-On-Skin Microfluidic Patch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lab-On-Skin Microfluidic Patch Market

34. Recent Developments In The Lab-On-Skin Microfluidic Patch Market

35. Lab-On-Skin Microfluidic Patch Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기